Active Pharmaceutical Ingredient Manufacturing: When Mixing Techniques Determine Quality

amixon® develops and manufactures mixers, dryers, and vacuum synthesis reactors for the pharmaceutical industry.

amixon® develops and manufactures mixers, dryers, and vacuum synthesis reactors for the pharmaceutical industry—for manufacturers and contract manufacturers (CDMOs) of APIs, finished pharmaceutical products, and biotechnologically produced active ingredients. The systems comply with GMP, FDA, and ATEX requirements and are designed for cleanroom compatibility, full cleaning validation, and process reproducibility.

The pharmaceutical industry is one of the most demanding sectors in process and process engineering. For manufacturers and contract manufacturers of active pharmaceutical ingredients (APIs) and finished pharmaceutical products, one key question takes center stage: How can the highest product quality be reliably ensured while maintaining process reliability, reproducibility, and regulatory compliance?

The real challenge: precision on a small scale
Pharmaceutical solid-state processes are not mass-production processes in the traditional sense. Active ingredients are often present in minimal concentrations—for example, just a few micrograms in a 500-mg tablet. The mixing ratio can be as high as 1:1,000 or even 1:5,000. At the same time, the physical properties of the powders, granules, and excipients used vary considerably: particle size, bulk density, and flow behavior determine whether a process runs stably or not.
The situation becomes even more complex when it comes to API synthesis. Whether the process is chemical or biotechnological, the reactants must be uniformly distributed at all times. Forming crystals must not be sheared or damaged, as crystal properties directly determine drug release and, consequently, bioavailability. Temperature gradients in the reactor are a frequently underestimated quality risk in this context.

Contract Manufacturers in Focus: Flexibility Is a Must
Contract pharmaceutical manufacturers (CDMOs) do not process a single product, but many—with changing formulations, different active ingredients, and varying batch sizes. Mixers, dryers, and reactors must therefore achieve consistent mixing quality at fill levels ranging from approximately 5% to 100% of the usable volume and be capable of being thoroughly cleaned in a manner that can be validated after each product change.
Closed, low-dust process chains (containment) are just as essential as comprehensive documentation in accordance with GMP requirements. Those who cannot provide robust cleaning validation risk not only product contamination but also regulatory consequences.

amixon® Solutions: Technology that grows with the task
amixon® develops and manufactures specialized mixing systems for the pharmaceutical industry in Paderborn. A key technical feature is the innovative SinConvex® mixing tool: It creates a three-dimensional redistribution of the material at very low speeds—without dead zones, gentle on sensitive structures, and efficient even with highly viscous materials or changing consistencies during the reaction.
For API synthesis, amixon® offers vacuum mixing dryers and synthesis reactors capable of mixing, drying, and temperature control simultaneously. Through large-surface-area heat exchanger walls—heated by steam, water, or thermal oil—temperatures in the reaction mixture can be precisely controlled without gradients. This is crucial for uniform nucleation during crystallization and thus for the reproducibility of active ingredient quality.
The conical vessel geometry (AM, AMT, KS series) in combination with the SinConvex® tool enables nearly complete residual discharge. This reduces product losses, simplifies cleaning, and significantly lowers the effort required for validation.

Built-in regulatory compliance
amixon® supports its customers in meeting key industry standards: GMP compliance, ATEX, FDA approval, and the full qualification chain (DQ / IQ / OQ / PQ). For pharmaceutical companies, this regulatory compliance is not an option—it is a prerequisite for market access.
Particularly valuable for manufacturers and contract manufacturers is the opportunity to test processes at the amixon® Technical Center in Paderborn using original ingredients. Mixing behavior, liquid addition, temperature control, vacuum drying, and discharge strategies can be examined under real-world conditions and specifically optimized—before an investment decision is made.